Balance Sheet

v3.24.1.1.u2

Condensed Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash	$ 3,274,314	$ 1,231
Deferred offering costs		303,281
Prepaid expenses	98,808	713
Due from related parties	130,000	130,000
Total current assets	3,503,122	435,225
Deferred Financing Costs		4,338,543
Total assets	3,503,122	4,773,768
Current liabilities:
Trade accounts payable and accrued liabilities	478,650	707,187
Due to related parties	7,902	527,377
Related party line of credit		101,000
Total current liabilities	486,552	1,335,564
Total liabilities	486,552	1,335,564
Stockholders’ Equity (Deficit)
Preferred Stock, no par value, 100,000,000 shares authorized and none issued or outstanding.
Common Stock, no par value; 300,000,000 shares authorized, 29,609,814 and 28,609,814 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively.
Additional paid-in capital	23,335,319	17,502,346
Accumulated deficit	(20,318,749)	(14,064,142)
Total stockholders’ equity	3,016,570	3,438,204
Total liabilities and stockholders’ equity	$ 3,503,122	$ 4,773,768

- Definition

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Source